Delivery Order SPE2DB20D7066-SPE2DB25FC3ZM

Award Date 7/9/25
Potential Completion Date 7/10/25
Potential Value $28K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,751.14, is for the delivery of ondansetron ODT 4 mg tablets. This is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,758.26, is for the delivery of 4,567,420,940 units of Ondansetron HCL 4 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,377.96, is for the delivery of 4,567,553,701 units of Ondansetron ODT 4 mg tablets. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,402.80 firm-fixed-price contract is for the delivery of Ondansetron HCL 4 mg tablets. The delivery order falls under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,205.20, is for the delivery of 4,559,799 units of the medication Ondansetron HCL 4 mg tablets. The contract has a firm fixed price and an ultimate completion date of February 2, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ondansetron HCL 4 MG Tablet UD 100S. The contract has a firm fixed price of $2,079.74 and a completion date of August 8, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999, for delivering a comprehensive range of medical commodities to support military...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,339.92 firm-fixed-price contract is for the supply of Ondansetron HCL 4 mg tablets. It is not designated as a set-aside contract, indicating open competition. The contract is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,895.46, is for the delivery of 4,568,077,758 units of Ondansetron HCl 4 mg tablets in 30-count packages. The contract is a firm-fixed price delivery order, with an ultimate completion date of April 30, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
This is a $20,519.83 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4563573519 Ondansetron ODT 4 mg Tablets 30s, and has an ultimate completion date of February 7, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,730.72 firm-fixed-price contract is for the delivery of 4,568,076 units of the medication Ondansetron HCL 4 mg tablets. The contract has an ultimate completion date of April 30, 2025 and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with...
  • SPE2DB20D7066
    Indefinite Delivery Contract
  • SPE2DB20D7066-SPE2DB25FC3ZM
    Delivery Order

This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,452.48 fixed-price contract is for the delivery of Ondansetron HCL 4 MG Tablets in 30-count packages. The delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This contract enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The current delivery order does not have a set-aside designation, indicating open competition.

Generated 10/12/25, 12:53 AM